Controlled vocabularies in bioinformatics: A case study in the Gene Ontology by Smith, Barry & Kumar, Anand
1741-8364/04/$ – see front matter ©2004 Elsevier Ltd. All rights reserved. PII: S1741-8364(03)02424-2
GO’s three ontologies
The Gene Ontology (GO) [1] is an important
tool for the representation and processing of
gene- and gene-product-related information
across all species. It provides a ‘controlled vo-
cabulary’, designed to support the work of re-
searchers in biomedicine by enabling them to
report their results by using a common termi-
nology in annotating genes and gene products.
When a gene is identified, three important
types of questions need to be addressed: where
is it located in the cell? What functions does it
have at the molecular level? And to what bio-
logical processes do these functions contribute?
GO’s controlled vocabulary is correspond-
ingly built out of three terminologies, consist-
ing of cellular component, molecular func-
tion and biological process terms, respectively.
As of March 15 2004, GO comprehends 1395
component terms, 7291 function terms and
8479 process terms. These form three separate
graphs, the primary purpose of which is to
allow researchers annotating genes and gene
products to locate the features and attributes
they are addressing in their work. Researchers
can then either choose corresponding terms
already existing within GO’s controlled vo-
cabulary or localize corresponding gaps in the
existing hierarchies and so recommend new
terms that need to be included.
GO’s cellular component ontology consists
of terms such as flagellum, chromosome, fer-
ritin and virion; terms that (with a few excep-
tions – above all the term ‘cell’ itself, as well as
‘extracellular matrix’ and ‘extracellular space’)
relate to entities properly included within a
single cell. All cellular components are, like
the cell itself, continuant entities (entities
which endure – which means that they pre-
serve their identity over time even while un-
dergoing changes of various sorts). [2] This
ontology is the counterpart in the GO envi-
ronment of what is otherwise called anatomy
(though GO also contains a fragmentary on-
tology of anatomical structures at levels of
granularity higher than that of the cell in its
treatment of terms such as fat body develop-
ment, gonad development, thyroid gland 
development, and so forth, in its biological
process ontology). The purpose of the cell
component ontology is to allow biologists to
register the physical structure with which a
gene or gene product is associated.
GO’s molecular function (activity) ontol-
ogy consists of terms such as ice nucleation
activity, binding and protein stabilization ac-
tivity. The GO definition of molecular func-
tion is ‘activities, such as catalytic or binding
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The automatic integration of information resources in the life sciences is
one of the most challenging goals facing biomedical informatics today.
Controlled vocabularies have played an important role in realizing this
goal,by making it possible to draw together information from heterogeneous
sources secure in the knowledge that the same terms will also represent
the same entities on all occasions of use. One of the most impressive
achievements in this regard is the Gene Ontology (GO), which is rapidly
acquiring the status of a de facto standard in the field of gene and gene
product annotations, and whose methodology has been much intimated
in attempts to develop controlled vocabularies for shared use in different
domains of biology. The GO Consortium has recognized, however, that 
its controlled vocabulary as currently constituted is marked by several
problematic features – features which are characteristic of much recent
work in bioinformatics and which are destined to raise increasingly serious
obstacles to the automatic integration of biomedical information in the
future. Here, we survey some of these problematic features, focusing
especially on issues of compositionality and syntactic regimentation.
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activities, at the molecular level.’ This ontology is thus in-
tended to consist of processes, in other words, occurrent
entities that do not endure but rather occur. Where the level
of granularity of the entities captured by GO’s cellular
component ontology is that of the cell, the molecular
function ontology comprehends functions/activities of
both intracellular and extracellular molecules.
GO’s biological process ontology consists of terms such
as ‘glycolysis’, ‘death’ and ‘adult walking behavior’ and in-
cludes terms referring to entities at both the cellular and
the whole organ or organism levels of granularity. A bio-
logical process is defined in GO as ‘a phenomenon marked
by changes that lead to a particular result, mediated by one
or more gene products.’ Molecular function and biological
process terms are thus clearly closely interrelated: both
refer to occurrent entities, in other words to entities that
unfold themselves in time.
What, now, is the relationship between biological
processes and molecular functions in the GO framework?
Certainly, there is such a relationship on the side of the
corresponding entities in reality. Thus the biological
process of anti-apoptosis, for example, clearly stands in
some relation to the molecular function labeled apoptosis
inhibitor activity. GO’s curators attempt to clarify this rela-
tionship by stating that ‘a biological process is accom-
plished via one or more ordered assemblies of molecular
functions’. This would suggest that molecular functions
are constituents of biological processes, so that they would
stand to such processes in a part-of relation. The problem
is, however, that the authors of GO insist at the same time
that the part-of relation can only occur between entities
within a single ontology. Thus, although they can capture
the relatively unproblematic part-hood relationships that
occur between biological processes and their biological
process parts they have no means of capturing the rela-
tionships between biological processes and the molecular
functions that underlie them. Thus receptor binding (a
molecular function) and signal transduction (a biological
process) are not related in the Gene Ontology, and neither
are transcription factor activity and development.
This is not as yet a fair ground for criticizing GO. The
principle according to which its three constituent ontolo-
gies should be kept free of relations linking them together
is a design choice that has borne considerable practical
fruit by allowing the construction of structured terminologies
with a wide coverage yet still a high degree of perspicuity.
The problems arising through the absence of cross-linkages
between GO’s three ontologies are also to some degree 
alleviated externally in virtue of the fact that the terms in
question do in any case become unified indirectly, where
single gene products are simultaneously annotated via
terms from different GO ontologies. Thus of the 84,833 
annotations within the Gene Ontology Annotation from
TIGR (GOAT) Database, [3] more than half were simul-
taneously annotated to terms within two of GO’s ontolo-
gies, and more than 10% were annotated to terms from all
three ontologies. We are currently analyzing these cases as
a basis for extending GO by establishing corresponding
cross-ontology links between the corresponding terms [4].
GO as a ‘controlled vocabulary’
GO’s considerable success is testimony to the wisdom of
several other crucial choices made by the GO Consortium
in the early stages of its development. Above all, the adop-
tion of a relatively simple graph-theoretic architecture
(Figure 1) involving just two kinds of edges (labeled ‘is_a’
and ‘part_of’) meant that work on populating GO could
proceed very quickly. Such work does not require the com-
pletion of complex protocols, but can be carried out intu-
itively by the expert biologist, who is subject to few formal
constraints when incorporating new terms and definitions.
In a series of recent papers we have attempted to show,
however, that there are also certain unintended negative
consequences of these choices. The problems turn on cer-
tain unanticipated consequences of these choices, above
all that they serve as an obstacle to the understanding of
Gene Ontology terms on the part of both curators and
users of GO, an obstacle that is perhaps most clearly illus-
trated in the instability in GO’s handling of the terms in its
function ontology, (almost) all of which were recently rela-
beled by appending the term ‘activity’ to each of the origi-
nal labels, without however any corresponding changes in
the accompanying definitions. More precisely, we have ar-
gued that the authors of the Gene Ontology have ignored
certain benefits which can accrue through the application
of formal and syntactic rigor in the formulation of terms
and definitions. The upshot is that there are aspects of
GO’s current architecture that are predestined to cause 
ever more serious problems as GO increases in size in the 
future. As the GO Consortium itself accepts, it will ‘be 
increasingly difficult to maintain the semantic consistency
we desire without software tools that perform consistency
checks and controlled updates’ [1]. However, much of the
information that GO contains is, under current policies,
not capable of being accessed or manipulated by software
tools.
For this, adherence to basic principles of logic is required,
and such principles are thus destined to play a vital role in
GO and similar bio-ontologies in the future as the obsta-
cles of manual inspection and supervision become ever
more significant. If formal tools are to be employed for
maintenance purposes, however, the information content
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of GO must be accessible to such tools. The language of GO
must therefore come to approximate more closely to a
compositional language, that is, a language wherein the
meaning of each compound expression is a function of the
meanings of its constituent parts. The GO Consortium has
acknowledged the significance of this fact and under the
auspices of the Open Biological Ontologies umbrella orga-
nization it is currently embarking on a program of reform,
which is in conformity with the proposals advanced here
and in our earlier papers. In [5], we focused especially on
inadequacies in GO’s specification of the relations between
its function and process ontologies, and on associated
problems with GO’s recent adoption of the suffix ‘activity’
to its function terms. In [6], we gener-
alized this critique by pointing to cer-
tain inadequacies in GO’s treatment of
the relationships between entities at
different levels of granularity. In [7]
(see also [8, 9]), we highlighted a series
of difficulties and uncertainties in GO’s
handling of its two foundational 
relations is_a and part_of, which con-
stitute the edges of the three graph-
theoretic hierarchies from which GO is
constituted. In [10], we added discus-
sion of formal inadequacies in GO’s 
definitions, attempting to show how
adherence to formal organizing princi-
ples drawn from philosophical ontol-
ogy, principles which represent best
practices in classification and defini-
tion, can lead to benefits in eliminat-
ing certain characteristic types of error
by which GO has hitherto been af-
fected.
Here, we turn to those aspects of GO’s
architecture, which have to do with its
status as a ‘controlled vocabulary.’ We
can summarize our argument in the
following four points:
i)  With the development of modern
formal disciplines (formal logic and
the computational disciplines which
have arisen in its wake) we have
learnt a great deal about the criteria
that must be satisfied if a language
is to be structured in such a way that
the information content expressed
by its means can be extracted via au-
tomatic procedures that can support
logical reasoning tools.
ii) GO’s controlled vocabulary has been developed in large
part without concern for these criteria – this applies
both to GOs terms and also to the definitions associ-
ated therewith. Accordingly GO has been used primarily
in support of statistics-based methodologies orientated
around string searches and pattern recognition, and
much of its information content has therefore not been
accessed.
iii) Aspects of GO’s current design, above all the expressive
paucity which flows from the absence of relationships
between the terms of its three constituent ontologies,
have led its curators to bend the rules of term-forma-
tion in order, in effect, to simulate such relations by
248
DDT: BIOSILICO Vol. 2, No. 6 November 2004
www.drugdiscoverytoday.com
REVIEWS
RESEARCH FOCUS
Figure 1. Relations between sample GO terms as rendered graphically by the QuickGO browser
(http://www.ebi.ac.uk/ego/) © European Bioinformatics Institute.
constructing artificial terms within which correspond-
ing relational expressions are embedded.
iv) Such artificial terms, however – for example ‘unlocal-
ized’ (with the meaning: localization not yet known) –
do not correspond to biological natural kinds: they are,
precisely, artifacts of the Gene Ontology itself; and be-
cause they are constructed by stretching the rules for
term-formation they create difficulties for curators who
apply GO in ways that often go hand in hand with
characteristic types of coding errors.
GO terms
The problem of expressive paucity created by GO’s limited
repertoire of relationships between its terms is to some 
extent counteracted through the policy of constructing
special terms that simulate representations of the missing
relationships within the very terms themselves. This is
achieved by means of special operators such as with, within,
without, in, site of, acting on, or resulting in. For example, the
term ‘electron transporter, transferring electrons within the
noncyclic electron transport pathway of photosynthesis
activity’; or ‘oxidoreductase activity, acting on diphenols
and related substances as donors, oxygen as acceptor’; or
‘oxidoreductase activity ,acting on paired donors, with 
oxidation of a pair of donors resulting in the reduction of
molecular oxygen to two molecules of water’. 
Some of these operators – for example ‘involved and in-
volving’ – were sometimes initially used to simulate the
presence of part_of and similar relations crossing bound-
aries between distinct ontologies. Others – for example
‘during’ – are used to simulate the presence of a vocabulary
for representing temporal relations. And yet others – for
example ‘within’ or ‘site of’ – are used to simulate spatial
relations and to compensate for the fact that GO has no
means of expressing the relation is_located_at – in spite of
the importance of the specification of cell locations to its
general mission.
Such construction of special terms on the part of GO’s
authors and curators has thus far been uncontrolled. The
result is that the operators in question are used in inconsis-
tent ways. This in turn means that the information they
express remains opaque to software tools.
Consider GO’s use of ‘involved in’ in assertions such as:
i) hydrolase activity, acting on acid anhydrides, involved
in cellular and subcellular movement is_a hydrolase activ-
ity, acting on acid anhydrides; ii) asymmetric protein
localization involved in cell fate commitment is_a cell fate
commitment; iii) cell-cell signaling involved in cell fate
commitment is_a cell fate commitment and iv) protein 
secretion involved in cell fate commitment synonym_of
protein secretion
The first assertion is correct to the degree that there are
indeed two subtypes of hydrolase activity acting on anhy-
drides: those that are and those that are not involved in
cellular and subcellular movement. However, GO has itself
declared the term at issue, ‘hydrolase activity, acting on
acid anhydrides, involved in cellular and subcellular move-
ment hydrolase activity’, which was taken over from the
Enzyme Commission, to be obsolete. This is because it is a
function term which also contains reference to biological
processes (cellular and subcellular movement), and this op-
poses GO’s principle that disallows links between its three
constituent ontologies.
The relationships at issue in the second and third asser-
tions are erroneously classified as is_a relations, as inspec-
tion reveals that we have to deal here rather with relations
of part_of. Thus, the instances of asymmetric protein locali-
zation, which are involved in instances of cell fate com-
mitment in fact form parts of the corresponding instances
of cell fate commitment. The problem with the second and
third assertions is that they have the same form as ‘breath-
ing involved in running is_a running’.
The fourth assertion equates the class of instances of
protein secretion that are involved in instances of cell fate
commitment with the class of instances of protein secre-
tion. This, again, is an example of erroneous coding, as
there are also instances of protein secretion that are not 
involved in cell fate commitment. The error flows in 
part from GO’s idiosyncratic understanding of ‘synonym’
(http://www.geneontology.org/GO.synonyms.html).
Similar problems arise also in connection with the ex-
pression ‘site of’, another example of an operator that is
used by GO in its efforts to compensate for the expressive
paucity of its repertoire of relations via the construction of
artificial terms. Use of ‘site of’ effectively converts the rela-
tion is_located_at into an is_a relation between specially
constructed terms. Unfortunately this device, too, proves
to be a source of errors – reinforcing our general point that
to bend the rules of term-formation involves paying a price
of unsure coding on the part of those who are then left
with no clear rules to follow.
Thus, as is shown in [7], from bud tip is_a site of polar-
ized growth (sensu Saccharomyces); and site of polarized
growth (sensu Saccharomyces) is_a site of polarized growth
(sensu Fungi), we can infer logically either i) that every in-
stance of non-Saccharomyces fungus polarized growth is
co-localized with an instance of Saccharomyces polarized
growth or (ii) that there is fungus polarized growth only in
Saccharomyces. The first example is taken to be biologi-
cally false; the second example however, implies that 
the terms ‘site of polarized growth (sensu Saccharomyces)’
and ‘site of polarized growth (sensu Fungi)’ in fact refer,
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confusingly, to the same class, and so the latter should be
removed from GO’s cellular component ontology. The 
lesson to be learned from this example is that there is a
logic to which one becomes committed when using terms
like ‘site of’ – a logic which may stand in conflict with the
logic to which one becomes committed when one uses
‘is_a’ and ‘part_of’ to form assertions by combining terms.
Problems with ‘Sensu’
Part of the problem just referred to derives from GO’s use
of what is perhaps the most important operator in the for-
mation of new terms, namely sensu. Sensu terms are intro-
duced to cope with those cases where a word or phrase has
different meanings when applied to different organisms, as
for example in the case of the cell wall. (Cell walls in bacte-
ria and in fungi have a completely different composition.)
Since it is a primary goal of the GO Consortium to pro-
vide an ontology of gene products applying to all species,
GO insists that sensu terms be introduced sparingly. In 
consequence, such terms often have non-sensu terms as
children, as for example in: R7 differentiation is_a eye pho-
toreceptor differentiation (sensu Drosophila).
GO’s interpretation of is_a sanctions the inference from
A is_a B to: every instance of A is an instance of B. If this is
correct, however, then this statement carries the implica-
tion that R7 differentiation occurs only in Drosophila,
which seems to stand in conflict with the fact that such
differentiation also occurs for example in crustaceans.
Analogous problems involving sensu and non-sensu terms
also arise in connection with GO’s part_of relation. Thus
we have: larval fat body development part_of larval devel-
opment (sensu Insecta), which seems to tell us that every
instance of larval fat body development occurs in insects,
which ignores for example the presence of fat bodies in
crustaceans and worms.
GO has responded to these concerns by pointing to spe-
cial features of its reading of ‘sensu’; by adding sensu the
idea was not to exclude certain taxa from being implied by
the use of a given sensu term, but rather to give a user an
idea of what sense a term should be used in. For example,
if another flying insect were to be annotated to GO, we
would hope that the ‘sensu Drosophila’ terms could be
used for this new species.
An example where you might want to annotate a gene
product from a taxon outside that specified in the sensu
designation is ‘fruiting body formation (sensu Dictyosteliida)’.
If you were annotating a gene from the subclass Myxogastria
(the true slime moulds, Dictyosteliida are the cellular slime
moulds) you would still use this term, because the process
in both taxa is identical (J Lomax personal communica-
tion).
Note that larval fat body development part_of larval de-
velopment (sensu Insecta) is an example of a sensu term
that has a non-sensu term as child. Such child-parent re-
lations might at first seem counter-intuitive, given that the
purpose of ‘sensu’ is precisely to allow a non-sensu term to
be modified in such a way that it can refer to entities
marked by special features which precisely do not arise in
the entities referred to by the term in its original unmodi-
fied form. Closer inspection reveals, however, that there
may be disadvantages to including the sensu designation
in all children of sensu terms. Thus the term ‘cell wall
(sensu Fungi)’ has the part_of child ‘hyphal cell wall’.
Because hyphae are only ever found in fungi it would then
be confusing to add the sensu qualifier to the term ‘hyphal
cell wall’ as this would suggest precisely that there were hy-
phal cell walls of other, non-fungal types. However, it is
important to note that the current rule, whereby the ‘sensu
X’ operator can be applied even to terms relating to taxa
disjoint from the taxon X creates one more barrier to the
automatic retrieval of information. This is because a term
like ‘Y (sensu X)’ identifies only indirectly the features
shared in common by all the Ys at issue – in a way that 
requires the intervention of a human biologist with the rel-
evant specialist knowledge. A better solution, therefore,
would be to replace such terms with terms of the form ‘Y
which is Z’, where ‘Z’ would then contain in explicit form
the relevant positive information about the peculiar fea-
tures at issue, rather than providing this information in
coded form via a (somewhat indeterminate) linkage to a
taxon.
Problems with syntactic operators
GO also employs a series of purely syntactic operators,
such as ‘,’, ‘/’, and ‘:’, in ways that seem to contravene the
underlying idea of a controlled vocabulary. Many of the
terms involving ‘,’ (for example 1,4 lactonase activity) are
standard IUPAC designations. Others, however, are prob-
lematic. Does the comma in ‘hydrolase activity, acting on
acid anhydrides’ mean ‘while’ or ‘of the type which is’?
Here the definition helps to resolve the issue in favor of
the latter, although as mentioned previously, the infor-
mation contained in GO’s definitions is not formulated in
such a way as to be accessible to software tools.
Problems arise also with GO’s inconsistent use of ‘/’. In
some cases GO’s ‘/’ means ‘and’, for example in GO:0005954
calcium/calmodulin-dependent protein kinase complex.
In others it means ‘or’, as in GO:0001539 ciliary/flagellar
motility. In yet other cases it means ‘and/or’, as in
GO:0045798 negative regulation of chromatin assembly/
disassembly. In GO:0008608 microtubule/kinetochore in-
teraction, it means ‘between’. In GO:0000082 G1/S transition
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of mitotic cell cycle ‘/’ it means ‘from … to …’. And in
GO:0001559 interpretation of nuclear/cytoplasmic to reg-
ulate cell growth it means ‘with respect to’. It may be that
human biologists find no difficulty in keeping control over
these and a range of other different meanings of a single
piece of syntax. What is certain, however, is that the infor-
mation that is currently coded by means of such operators
is to a large degree masked to automatic tools for infor-
mation extraction. We are thus gratified to see that reforms
are currently under way by virtue of which the treatment
of syntactical and other operators will be standardized
through the imposition of a set of rules governing the use
of these operators in different ontologies within the OBO
framework.
In Table 1, we provide a list (which complements the dis-
cussion in [11]) of the more important syntactic operators
in GO, to give some idea of the scale of the problems at
issue – problems which are currently being addressed by
the GO consortium under the auspices of its OBOL project.
In the left-hand column are the terms or syntactic operators
that contribute to the compositional character of GO –
they are, as it were, standard linking expressions in terms
of which complex terms are built up out of simpler parts.
Examples in the next column are selected to illustrate how
these linking expressions are characteristically used. The
remaining columns give information as to the number of
uses of the expressions in question in GO’s three ontologies.
Conclusions
As the GO consortium has recognized (Mungall, C. et al.
The OBOL Ontology Language, unpublished), many of the
problems connected with GO’s departure from composi-
tionality can be resolved by preparing a canonical list of
admissible operators and providing strict usage rules for
each. The terms involving such operators currently receive
a significantly lower number of annotations than do other
terms in GO. This, we believe, provides some indication
that the meanings conveyed by the terms in question are
not only inaccessible to software tools but also to human
biologists who find them difficult to understand. These 
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Table 1.
Operator Examples Component
ontology
Function
ontology
Process
ontology
With GO: 0010483 conjugation with cellular fusion 1 17 36
Within GO: 0045153 electron transporter, transferring electrons within
CoQH2-cytochrome
c reductase complex activity
1 5 8
Without GO: 0000748 conjugation without cellular fusion 0 0 10
From GO: 0019285 betaine biosynthesis from choline 0 2 139
During GO: 0042074 cell migration during gastrulation 0 0 73
And GO: 0016743 carboxyl- and carbamoyltransferase activity 2 42 136
In GO: 000014 G1-specific transcription in mitotic cell cycle 0 18 32
Acting on GO: 0016684 oxidoreductase activity, acting on peroxide as acceptor 0 145 1
Resulting in GO: 0000077 DNA damage response, signal transduction resulting in cell
cycle arrest
0 1 7
Regulator; GO: 0042754 negative regulation of circadian rhythm 0 66 1260
Regulatory; GO:0045055 regulated secretory pathway
Regulated;
Regulation
Dependent GO: 0004692 cGMP-dependent protein kinase activity 14 90 78
Constituent, GO: 0030280 structural constituent of epidermis 0 28 1
Constitutive
Response GO: 0000751 cell cycle arrest in response to pheromone 0 5 261
Sensu GO: 0000143 actin cap (sensu Saccharomyces) 140 14 315
Site of GO: 0016366 site of polarized growth 3 0 1
Complex GO: 0015667 proteasome activator complex 518 11 34
: (colon) GO: 0015296 anion:cation symporter activity 3 170 4
/ (slash) GO: 0000871 pilin / fibrilin exporter activity 12 112 162
, (comma) GO: 0002279 cyclin-dependent protein kinase, intrinsic regulator activity 71 724 411
examples highlight general concerns about the develop-
ment and maintenance of systems like GO in the future.
Terminologies are likely to be less susceptible to error and
also more susceptible to integration with other terminolo-
gies if they are subjected to robust principles for handling
syntax and for formulating terms and definitions.
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AGORA initiative provides free agriculture journals to developing countries
The Health Internetwork Access to Research Initiative (HINARI) of the WHO has launched a new community scheme with the
UN Food and Agriculture Organization.
As part of this enterprise, Elsevier has given 185 journals to Access to Global Online Research in Agriculture (AGORA).
More than 100 institutions are now registered for the scheme, which aims to provide developing countries with free access to
vital research that will ultimately help increase crop yields and encourage agricultural self-sufficiency.
According to the Africa University in Zimbabwe,AGORA has been welcomed by both students and staff. ‘It has brought a
wealth of information to our fingertips’ says Vimbai Hungwe. ‘The information made available goes a long way in helping the
learning, teaching and research activities within the University. Given the economic hardships we are going through, it couldn’t
have come at a better time.’
For more information visit:
http://www.healthinternetwork.net
